Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi Center Clinical Study to Evaluate the Safety And Effectiveness of the Transform™ Corneal Allograft (TCA) for Treatment of Hyperopia

NCT03671096 is registered in ClinicalTrials.gov with Allotex, Inc. as lead sponsor.

NCT NCT03671096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03671096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi Center Clinical Study to Evaluate the Safety And Effectiveness of the Transform™ Corneal Allograft (TCA) for Treatment of Hyperopia
Lead sponsor
Allotex, Inc.
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2018
Completion date
January 31, 2021
Enrollment
0 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

hyperopia